Sinclair Pharma Share Discussion Threads

[abcd1234] 10/6/2014 11:53

broker note circulating

[mrmomentumt] 10/6/2014 09:55

Thanks for the summary John!

[johnwise] 10/6/2014 09:54

mrmomentumt,

Director Dealings in Sinclair IS Pharma plc

07-May-14 Buy Robert Stuart Swanson 30.50p 319,146 Shares
Value £97,339.53

02-May-14 Buy Robert Stuart Swanson 30.62p 900,000 Shares
Value £275,589.01

01-May-14 Placing Robert Stuart Swanson 32.00p 3,125,000 Shares
Value £999,999.98

01-May-14 Placing Jean-Charles Tschudin 32.00p 500,000 Shares
Value £160,000.00

01-May-14 Buy Robert Stuart Swanson 30.67p 320,226 Shares
Value £98,216.52

30-Apr-14 Buy Robert Stuart Swanson 30.50p 12,774 Shares Value £3,896.07

30-Apr-14 Buy Chris Spooner 30.88p 343,471 Shares Value £106,046.67

29-Apr-14 Buy Robert Stuart Swanson 30.75p 154,225 Shares
Value £47,424.19

25-Apr-14 Buy Robert Stuart Swanson 30.50p 44,131 Shares
Value £13,459.96

24-Apr-14 Buy Robert Stuart Swanson 30.50p 25,555 Shares Value £7,794.28

22-Apr-14 Buy Robert Stuart Swanson 30.50p 16,089 Shares Value £4,907.15

[mrmomentumt] 10/6/2014 09:43

John I certainly feel reassured. The more a director buys and the number he holds shows a great deal of confidence in the prospects of the business imo. Putting their money where their mouth is a big positive in my book as people rarely plough their own cash into something they feel will crash and burn. They usually do it with a view to increasing their wealth over the longer term.

[eggbaconandbubble] 10/6/2014 09:20

John, with all respect if you look at the stream of director purchases and specifically Mr Swanson I don't feel any great surge in my own reassurance.

[mrmomentumt] 10/6/2014 09:20

Some nice buying going through this morning, inc a nearly £40k purchase!

[johnwise] 10/6/2014 07:45

Yes, Reassuring to se a Director buying more of the company

RNS Number : 2032J
10 June 2014

[mrmomentumt] 10/6/2014 07:36

Another 50k bought:)

10 June 2014
Directors' Dealings


Sinclair IS Pharma plc (SPH.L), ("Sinclair" or the "Group") the international specialty pharma company, was informed on 9 June 2014 that earlier that day Stuart Swanson, a Non-Executive Director, acquired 50,000 ordinary shares in Sinclair at an average price of 29.75p per share. Following this purchase Stuart Swanson has a beneficial interest in 9,250,000 ordinary shares representing 1.86% of the Group's issued ordinary share capital.

[mrmomentumt] 09/6/2014 18:49

Quite happy with the funds buying in. Just wondered whether the chap who called offering £3-5 for shares was a scam artist and whether what he was proposing was a boiler room type fraud. I have held SPH for some time now.

[johnwise] 09/6/2014 13:26

mrmomentumt,,

The billionaire George Soros, has bought into Sinclair Pharma

Soros Fund Management LLC: Holding 25,000,000 Valued at £7,625,000

[johnwise] 09/6/2014 09:03

mrmomentumt,

The Directors and Pension funds have been buying big time

[mrmomentumt] 09/6/2014 08:30

Is this what they refer to as a boiler room scam? If it sounds too good to be true....

[tackems] 07/6/2014 16:30

Just that ebandb, he had an American accent with a (possibly) far east twang and I asked him to repeat the range that he would buy at on behalf of his client!

I have had those sort of calls before but this is the first one for SPH.

He also mentioned that his client wanted to take over the company!

[eggbaconandbubble] 07/6/2014 08:09

Tackems, what do you mean by £3 -£5???

[tackems] 06/6/2014 21:41

Agreed Red, that's why I said no but it is interesting that they would chase stock and the share price is still being held down with significant buys going through.

[red ninja] 06/6/2014 15:04

mmm, sounds like a con if they are talking £3 - £5

[eggbaconandbubble] 05/6/2014 18:45

mrmoment. Can you paste his blog here. Cheers

[gobbie100] 05/6/2014 18:39

£3-£5 sound a good deal for a 30p share. Sell em!

[tackems] 05/6/2014 18:14

Just had a phone call from someone (would not give his name) in Chicago asking if I would be interested in selling my shares to an outfit who want to gain 51% - of course he would not disclose who! He was offering to buy within the range of £3 to £5 maximum. I declined but I wonder if it's to do with all the share activity over the last few months and the apparent 'manipulation' to keep the share price at a lowish level even though there have been significant buys.

[mrmomentumt] 05/6/2014 12:25

I note John Rosier has taken a position in SPH and is very bullish! Looking forward to good things ahead!

[johnwise] 04/6/2014 06:53

4 June 2014 "Whispers within the health care industry now suggest that the weak share price is attracting cash-rich predators".


MARKET REPORT: Sinclair IS Pharma shares drifting since George Soros increased stake in aesthetics and skin care company

Eyebrows were raised when George Soros recently spent £9m in taking his stake in aesthetics and skin care company Sinclair IS Pharma above 5 per cent by acquiring more stock at 32p a pop.

Dealers asked why would the infamous hedge fund investor be interested in an AIM-listed company with a market capitalisation of 'only' £126m? With his track record, surely the only way must be up and he must know something. Yet since his purchase, talk of a stock overhang has seen the shares drift and last night's close was down 0.25p at 29p.

Whispers within the health care industry now suggest that the weak share price is attracting cash-rich predators.

Private equity players have been sniffing around for a while but Nestle, the Swiss food giant, which in February announced a new specialised medical skin care division, is strongly rumoured to have knocked on Sinclair's door with a 'friendly' proposal.

Sinclair IS Pharma earlier this year paid £69.9m for Silhouette, a company that has found a replacement for botox. Silhouette Soft is a £1,200 anti-ageing treatment that uses dissolvable thread to beat wrinkles.

Sinclair would therefore be a perfect bolt-on for Nestle, which recently acquired the rights to sell certain skin care products in the US and Canada from Valeant Pharmaceuticals, based in Quebec, for £840m cash.

It included the full rights to Sculptra, a unique treatment for aesthetic and medical uses in the US, Canada and many markets around the world.



Sinclair IS Pharma PLC Holding(s) in Company

[dealit] 13/5/2014 10:14

Toscafund now have over 29%.

[scargs] 10/5/2014 17:21

Possibly the Financial Times have made a mistake calling him Robert, as opposed to Stuart.

The point is that Mr Swanson has a load of shares that has cost him a significant amount of money, he is a veteran of the industry and no doubt well connected.

All of this augurs well for Sinclair IS Pharma.

Time will tell, but it gives me a great deal of comfort, as a shareholder, to know that Mr Swanson is on board.